Aquestive Therapeutics, Inc. (AQST) vs Crescent Biopharma, Inc. (CBIO)
A side-by-side comparison of Aquestive Therapeutics, Inc. and Crescent Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AQST
Aquestive Therapeutics, Inc.
$4.53HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT
CBIO
Crescent Biopharma, Inc.
$14.30HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT
Total return — AQST vs CBIO
growth of $100 · dividends reinvested · last 8yAQST -71.5% (-14.5%/yr)CBIO -97.1% (-35.8%/yr)AQST compounded faster over this window
Log scale — wide-divergence pair
AQST CBIO
AQST vs CBIO: by the numbers
- •AQST is the larger company ($568M vs $531M market cap).
- •Both run net losses; AQST's is the smaller (-144.63% vs -1371.51% net margin).
- •CBIO grew revenue faster over the past five years (39.89% vs -0.58% CAGR).
Metrics side by side
Valuation
| Metric | AQST | CBIO |
|---|---|---|
| P/S ratio | 10.51 | 44.70 |
| P/B ratio | N/A | 3.34 |
Profitability
| Metric | AQST | CBIO |
|---|---|---|
| Gross margin | 67.04% | 100.00% |
| Operating margin | -156.36% | -1407.52% |
| Net margin | -144.63% | -1371.51% |
| ROE | N/A | -99.83% |
| ROIC | -45.62% | -102.59% |
Growth (annualized)
| Metric | AQST | CBIO |
|---|---|---|
| Revenue CAGR (5Y) | -0.58% | 39.89% |
| Total return CAGR (5Y) | 2.24% | -24.40% |
Frequently asked
- Which has grown faster, AQST or CBIO?
- Over the past five years, CBIO grew revenue faster — AQST at a -0.58% CAGR versus CBIO at 39.89%.
- How have AQST and CBIO total returns compared?
- Over the past 5 years, AQST delivered 2.24% and CBIO delivered -24.40% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Aquestive Therapeutics ROECrescent Biopharma ROEAquestive Therapeutics operating marginCrescent Biopharma operating marginAquestive Therapeutics revenue growthCrescent Biopharma revenue growthAquestive Therapeutics free cash flowCrescent Biopharma free cash flow
Aquestive Therapeutics & Crescent Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.